The interaction between histoplasma capsulatum cell wall carbohydrates and host components: Relevance in the immunomodulatory role of histoplasmosis

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 3, 2009, Pages 492-496

  Gorocica, Patricia ^a   Taylor, Maria Lucia ^b   Alvarado Vásquez, Noé ^a   Pérez Torres, Armando ^c   Lascurain, Ricardo ^a,d   Zenteno, Edgar ^d  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b Microbiología y Parasitolo gia ^*

^c Biología Celular y Tisular   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Carbohydrates; Glucans; Histoplasma capsulatum; Immunomodulation; Polysaccharides

Indexed keywords

AJELLOMYCES CAPSULATUS;

EID: 67649497105     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000300016     Document Type: Article

References (50)

1. Azuma I, Kanetsuna F, Tanaka Y, Yamamura Y, Carbonell LM 1974. Chemical and immunological properties of galactomannans obtained from Histoplasma duboisii, Histoplasma capsulatum, Paracoccidioides brasiliensis and Blastomyces dermatitidis. Mycopath Mycol Appl 54: 111-125.
2. Barr K, Laine RA, Lester RL 1984. Carbohydrate structures of three novel phosphoinositol-containing sphingolipids from the yeast Histoplasma capsulatum. Biochemistry 23: 5589-5596.
3. Barr K, Lester RL 1984. Occurrence of novel antigenic phosphoinositol-containing sphingolipids in the pathogenic yeast Histoplasma capsulatum. Biochemistry 23: 5581-5588.
4. Bernard M, Latgé JP 2001. Aspergillus fumigatus cell wall: composition and biosynthesis. Med Mycol 39 (Supl. 1): 9-17.
5. Bittencourt VC, Figueiredo RT, da Silva RB, Mourão-Sá SD, Fernande P, Sassaki GL, Mulloy B, Bozza MT, Barreto-Bergter E 2006. An α-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and toll-like receptor activation. J Biol Chem 218: 22614-22623.
6. Brown GD 2006. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6: 33-43.
7. Bullock WE, Wright SD 1987. Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J Exp Med 165: 195-210.
8. Davis TE Jr, Domer JE, Li YT 1977. Cell wall studies of Histoplasma capsulatum and Blastomyces dermatitidis using autologous and heterologous enzymes. Infect Immun 15: 978-987.
9. Deepe GS Jr 2007. Tumor necrosis factor alpha and host resistance to the pathogenic fungus, Histoplasma capsulatum. J Invest Dermatol Symp Proc 12: 34-37.
10. Deepe GS Jr, Gibbons RS 2006. T cells require tumor necrosis factor a- to provide protective immunity in mice infected with Histoplasma capsulatum. J Infect Dis 193: 322-330.
11. Dennehy KM, Brown GD. 2007. The role of the β-glucan receptor Dectin-1 in control of fungal infection. J Leukoc Biol 82: 253-258.
12. Dickson RC, Lester RL 1999. Yeast sphingolipids. Biochem Biophys Acta 1426: 347-357.
13. Domer JE 1971. Monosaccharide and chitin content of cell walls of Histoplasma capsulatum and Blastomyces dermatitidis. J Bacteriol 107: 870-877.
14. Domer JE, Hamilton JG, Harkin JC 1967. Comparative study of the cell walls of the yeast-like and mycelial phases of Histoplasma capsulatum. J Bacteriol 94: 466-474.
15. Duarte-Escalante E, Zenteno E, Taylor ML 2003. Interaction of Histoplasma capsulatum yeasts with galactosylated surface molecules of murine macrophages. Arch Med Res 34: 176-183.
16. Eissenberg LG, Goldman WE 1991. Histoplasma variation and adaptive strategies for parasitism: new perspectives on histoplasmosis. Clin Microbiol Rev 4: 411-421.
17. Eissenberg LG, Moser SA, Goldman WE 1997. Alterations to the cell wall of Histoplasma capsulatum yeasts during infection of macrophages or epithelial cells. J Infect Dis 175: 1538-1544.
18. Eissenberg LG, Poirier S, Goldman WE 1996. Phenotypic variation and persistence of Histoplasma capsulatum yeasts in host cells. Infect Immun 64: 5310-5314.
19. Gómez AM, Rhodes JC, Deepe GS Jr 1991. Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun 59: 330-336.
20. Jiménez-Lucho V, Ginsburg V, Krivan HC 1990. Cryptococcus neoformans, Candida albicans and other fungi bind specifically to the glycosphingolipid lactosylceramide (Galβ1-4Glcβ1-1Cer), a possible adhesion receptor for yeasts. Infect Immun 58: 2085-2090.
21. Kanetsuna F 1981. Ultraestructural studies on the dimorphism of Paracoccidiodes brasiliensis, Blastomyces dermatitidis and Histoplasma capsulatum. Sabouraudia 19: 275-286.
22. Kanetsuna F, Carbonell LM, Gil F, Azuma I 1974. Chemical and ultrastructural studies on the cell walls of the yeast like and mycelial forms of Histoplasma capsulatum. Mycopath Mycol Appl 54: 1-13.
23. Kataoka K, Muta T, Yamazaki S, Takeshige K 2002. Activation of macrophages by linear (1-3)-β-D-glucans. Implications for the recognition of fungi by innate immunity. J Biol Chem 277: 36825-36831.
24. Klimpel KR, Goldman WE 1988. Cell walls from avirulent variants of Histoplasma capsulatum lack α-(1,3)-glucan. Infect Immun 56: 2997-3000.
25. Kügler S, Schurtz-Sebghati T, Eissenberg LG, Goldman WE 2000. Phenotypic variation and intracellular parasitism by Histoplasma capsulatum. Proc Natl Acad Sci USA 97: 8794-8798.
26. Long KH, Gomez FJ, Morris RE, Newman SL 2003. Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. J Immunol 170: 487-494.
27. Lu J, Teh C, Kishore U, Reid KB 2002. Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochem Biophys Acta 1572: 387-400.
28. Maldonado G, Gorocica P, Agundis C, Pérez A, Molina J, Zenteno E 1998. Inhibition of phagocytic activity by the N-acetyl-D-galactosamine specific lectin from Amaranthus leucocarpus. Glyconjugates J 15: 615-622.
29. Marion CL, Rappleye CA, Engle JT, Goldman WE 2006. An α-(1,4)-amylase is essential for α-(1,3)-glucan production and virulence in Histoplasma capsulatum. Mol Microbiol 62: 970-983.
30. Marth T, Kelsall BL 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med 185: 1987-1995.
31. Matsuo AL, Tersariol II, Kobata SI, Travassos LR, Carmona AK, Puccia R 2006. Modulation of the exocellular serine-thiol proteinase activity of Paracoccidioides brasiliensis by neutral polysaccharides. Microbes Infect 8: 84-91.
32. McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, Deepe GS Jr 2003. Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 278: 3625-3626.
33. McMahon JP, Wheat J, Sobel ME, Pasula R, Downingm JF, Martin II WJ 1995. Murine laminin binds to Histoplasma capsulatum. A possible mechanism of dissemination. J Clin Invest 96: 1010-1017.
34. Medeiros AI, Silva CL, Malheiro A, Maffei CML, Faccioli LH 1999. Leukotrienes are involved in leukocyte recruitment induced by live Histoplasma capsulatum or by the β-glucan present in their cell wall. Br J Pharmacol 128: 1529-1537.
35. Meier A, Kirschning CJ, Nikolaus T, Wagner H, Heesemann J, Ebel F 2003. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol 5: 561-570.
36. Obei LM, Okamoto Y, Mao C 2002. Yeast sphingolipids: metabolism and biology. Biochem Biophys Acta 1585: 163-171.
37. Pereira-Morales MA, Merchant MTN, Reyes-Montes MR, Toriello C, Agundis-Mata C, Flores-Robles E, Taylor ML 1998. Inmunolocalización del complejo polisacárido-proteína en ultraestructuras de la fase micelial y levaduriforme de Histoplasma capsulatum. Rev Ins Nal Enf Resp Mex 11: 237-242.
38. Rappleye CA, Eissenberg LG, Goldman WE 2007. Histoplasma capsulatum α-(1,3)-glucan blocks innate immune recognition by the β-glucan receptor. Proc Natl Acad Sci USA 104: 1366-1370.
39. Rappleye CA, Engle JT, Goldman WE 2004. RNA interference in Histoplasma capsulatum demonstrates a role for α-(1,3)-glucan in virulence. Mol Microbiol 53: 153-165.
40. Reiss E, Miller SE, Kaplan W, Kaufman L 1977. Antigenic, chemical and structural properties of cell walls of Histoplasma capsulatum yeast-form chemotypes 1 and 2 after serial enzymatic hydrolysis. Infect Immun 16: 690-700.
41. Reiss E, Mitchell WO, Stone SH, Hasenclever HF 1974. Cellular immune activity of a galactomannan-protein complex from mycelia of Histoplasma capsulatum. Infect Immun 10: 802-809.
42. Rementeria A, Abaitua F, Garcia-Tobalina R, Hernando F, Ponton J, Sevilla MJ 1997. Resistance to candidiasis and macrophage activity in chitin-treated mice. FEMS Immunol Med Microbiol 19: 223-230.
43. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Karting HC 2004. Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 42: 485-498.
44. Ross GD 2002. Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion. Immunol Res 25: 219-227.
45. Ruiz-Herrera J 1992. Chemical composition of the fungal cell wall. Isolation of cell wall. In J Ruiz-Herrera, Fungal cell wall: structure. Synthesis and assemble, CRC Press, Boca Raton, p. 5-22.
46. Taylor ML, Bojalil LF 1977. Inmunología de la histoplasmosis: Aislamiento de un complejo polisacárido-proteína con actividad in- munoespecífica a partir de Histoplasma capsulatum. Arch Invest Med Mex 8: 91-102.
47. Taylor ML, Duarte-Escalante E, Pérez A, Zenteno E, Toriello C 2004. Histoplasma capsulatum yeast cells attach and agglutinate human erythrocytes. Med Mycol 42: 287-292.
48. Taylor ML, Duarte-Escalante E, Reyes-Montes MR, Elizondo N, Maldonado G, Zenteno E 1998. Interaction of murine macrophage-membrane proteins with components of the pathogenic fungus Histoplasma capsulatum. Clin Exp Immunol 113: 423-428.
49. Taylor ML, Reyes-Montes MR, Lachica A, Eslava-Campos C, Olvera J, Maxwell R 1980. Immunology of histoplasmosis: humoral and cellular activity from a polysaccharide-protein complex and its deproteinized fraction in experimentally immunized mice. Mycopathologia 71: 159-166.
50. Xia Y, Vetvicka V, Yan J, Hanikyrova M, Mayadas T, Ross GD 1999. The β-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J Immunol 162: 2281-2290.